SEC clears listing for first 3x bitcoin and ether products in the US

What happened

The US Securities and Exchange Commission has approved an exchange rule change that will allow the first triple-leveraged bitcoin and ether products to list in the United States. The approval, dated October 2, covers a filing by Cboe BZX to list six products from a single issuer, each designed to deliver three times the daily return of its reference asset. Two of the six track crypto assets, bitcoin and ether. The other four cover gold, silver, crude oil and natural gas. Until this approval, leveraged crypto products available in the US had been limited to twice the daily return.

The structure matters more than the headline number. These are not spot funds that hold bitcoin or ether directly. Each product gains its exposure through regulated futures contracts tied to the reference asset. The listing approval therefore concerns exchange rules for commodity-based trust shares, not the registration of a conventional investment company fund. The issuer still needs the agency to declare its registration statement effective before any shares can be sold to the public, and the approval order sets no deadline for that step. In practical terms, the products are cleared to list once registration is effective, but they cannot trade yet. The leveraged products that US investors can already trade remain the existing two-times funds.

Leverage in these products resets every day. The fund targets three times the return for a single day, then rebalances to restore that exposure for the next day. After a gain, the fund must add futures exposure to stay at three times the new, larger asset base. After a loss, it must cut exposure. Those adjustments tend to cluster near the market close and grow in size with the fund itself. The daily reset is the defining feature, and it is why the products behave differently over longer periods from a simple multiplication of the underlying return.

CoinDesk reporting on the approval also highlighted the cost that comes from holding futures. As a futures contract approaches expiry, the fund sells it and buys a later-dated contract to maintain exposure. When later contracts trade above nearer ones, that roll creates a steady drag. The issuer's preliminary filing flags volatility itself as a risk factor, noting that a more volatile reference asset increases the potential for losses from the reset mechanism. The filing describes the products as speculative and warns that an investor could lose a large portion or all of the amount invested in a severe single-day move.

Why it matters

The approval extends the range of crypto exposure that can be bought and sold through a US brokerage account, but it does so at the high-risk end of that range. Spot funds give one-to-one exposure to price movements minus fees. Two-times products double the daily move. Three-times products triple it, with the same daily reset that makes multi-day outcomes path-dependent. That path dependence is easy to underestimate. Consider a reference asset that rises 10 percent on one day and falls 10 percent the next. The asset itself ends about 1 percent lower over the two days. A product targeting three times the daily return would gain about 30 percent on the first day and lose about 30 percent on the second, ending about 9 percent lower. The gap widens when prices swing back and forth without a clear trend. This effect, often called volatility decay, means a trader can be right about the eventual direction and still lose money if the path is choppy.

For that reason, commentary around the approval has stressed the intended holding period. The products are built for short-term trading around a daily view, not for set-and-hold exposure. A position held for weeks accumulates the effect of every daily reset, plus futures roll costs and fund fees, so its return can diverge sharply from three times the underlying return over the same weeks, and can diverge in the opposite direction in extreme cases. Readers who compare these products to spot funds should keep the comparison on a single-day basis, where the target is defined, and treat any longer comparison as a different claim that the product does not make.

The approval also shows how product structure influences regulatory outcomes. Because the new products are organized as commodity trusts holding futures, they sit outside the leverage limits that apply to funds registered under the investment company framework, where agency staff had previously declined to advance triple-leveraged proposals over concerns about portfolio risk limits. Routing the same economic exposure through a different statutory wrapper is what made the listing possible. That distinction will matter for future filings. Other issuers seeking higher leverage will study which wrapper was used, which exchange rule was amended, and what disclosures the agency required about daily resets and futures costs.

Market impact is the final dimension. Daily rebalancing creates predictable buying after gains and selling after losses. In a small fund, those flows are negligible. In a large fund tied to a volatile reference asset, they can add to moves near the close, particularly on days with large swings. Whether that effect becomes material depends entirely on how much money the products gather once they launch. At the approval stage, with no trading and no assets disclosed, the effect is theoretical. Assets under management after launch will be the number that decides whether it stays theoretical.

What to watch

The immediate marker is registration. Watch for the registration statement to be declared effective and for the issuer to announce tickers, fees and a launch date. Without that step, the approval has no tradable product attached to it. The fee level will matter in practice, because a high fee compounds the drag from daily resets and futures rolls for anyone who holds beyond a day.

The second marker is early trading behavior. On the first large up and down days after launch, compare each product's daily return to three times the daily return of its futures reference. Close tracking on a single day would confirm the mechanism works as described. Any gap would raise questions about futures liquidity or rebalancing execution that deserve attention before assets grow.

The third marker is competitive response. If the triple-leveraged products attract meaningful trading volume, other issuers may file for similar exposure through the same trust structure and exchange rule. Watch for new filings that cite this approval, and for any agency comment that narrows or widens the path it opened. A single approval can remain an exception, or it can become the template for a product category. The filings that follow will show which.

The fourth marker is investor communication at the point of sale. Brokerage platforms decide how prominently they display the daily-reset warning and the risk of total loss. Clear labeling will not remove the risk, but it will affect who buys the product and for what purpose. For now, the confirmed event is the October 2 listing approval itself. No triple-leveraged bitcoin or ether product is trading yet, and the next step belongs to the registration process.